220 related articles for article (PubMed ID: 9676130)
1. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
2. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
Nadeem A; Hussain MM; Aslam M
J Coll Physicians Surg Pak; 2010 Oct; 20(10):657-61. PubMed ID: 20943107
[TBL] [Abstract][Full Text] [Related]
4. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
5. Iron depletion and response to interferon in chronic hepatitis C.
Carlo C; Daniela P; Giancarlo C
Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
[TBL] [Abstract][Full Text] [Related]
6. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
7. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
8. Use of phlebotomy treatment in Atlantic bottlenose dolphins with iron overload.
Johnson SP; Venn-Watson SK; Cassle SE; Smith CR; Jensen ED; Ridgway SH
J Am Vet Med Assoc; 2009 Jul; 235(2):194-200. PubMed ID: 19601742
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
10. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
Iwasa M; Kaito M; Ikoma J; Kobayashi Y; Tanaka Y; Higuchi K; Takeuchi K; Iwata K; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(44):529-31. PubMed ID: 11995488
[TBL] [Abstract][Full Text] [Related]
11. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
13. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
[TBL] [Abstract][Full Text] [Related]
14. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
[TBL] [Abstract][Full Text] [Related]
15. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
Parolin MB; Lacerda MA; Lopes RW
Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
[TBL] [Abstract][Full Text] [Related]
16. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
18. Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran.
Ameli M; Besharati S; Nemati K; Zamani F
Saudi Med J; 2008 Nov; 29(11):1611-5. PubMed ID: 18998011
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
[TBL] [Abstract][Full Text] [Related]
20. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]